Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7.36x is 34% above its 5-year average of -11.19x, near the high end of its 5-year range (-43.55x–-0.41x).
As of the fiscal period ended Thursday, March 31, 2022. 44.85% above its 12-month average of -13.34x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-03-31): -7.36x.
INTEREST COVERAGE RATIO
-7.36x
INTEREST COVERAGE RATIO AVG TTM
-13.34x
INTEREST COVERAGE RATIO AVG 3Y
-13.34x
INTEREST COVERAGE RATIO AVG 5Y
-11.19x
INTEREST COVERAGE RATIO AVG 10Y
-0.92x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+44.85%
CURRENT VS 3Y AVG
+44.85%
CURRENT VS 5Y AVG
+34.23%
CURRENT VS 10Y AVG
-698.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-27.09%
vs the sector median at left
Modular Medical, Inc.
Market Cap
$21.76M
Interest Coverage Ratio
-7.36x
TTM Avg
-13.34x
3Y Avg
-13.34x
5Y Avg
-11.19x
Market Cap
$22.11M
Interest Coverage Ratio
4.39x
TTM Avg
4.39x
3Y Avg
4.39x
5Y Avg
4.39x
Market Cap
$20.80M
Interest Coverage Ratio
-24.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.76M
Interest Coverage Ratio
-1110.88x
TTM Avg
1344.27x
3Y Avg
1344.27x
5Y Avg
1344.27x
Market Cap
$19.67M
Interest Coverage Ratio
-4.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.60M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.09M
Interest Coverage Ratio
-5.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Modular Medical, Inc. (MODD) | $21.76M | -7.36x | -13.34x | -13.34x | -11.19x |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | 4.39x | 4.39x | 4.39x | 4.39x |
| LeonaBio, Inc. (LONA)vs › | $22.36M | N/A | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.80M | -24.74x | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $23.04M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.76M | -1110.88x | 1344.27x | 1344.27x | 1344.27x |
| P3 Health Partners Inc. (PIII)vs › | $19.67M | -4.91x | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.60M | N/A | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.09M | -5.24x | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $18.95M | N/A | N/A | N/A | N/A |
Interest Coverage
-7.4x
Debt/Equity
0.03
Current Ratio
3.25
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-03-31 | -7.36x |
| 2021-12-31 | -3.79x |
| 2021-09-30 | -5.39x |
| 2021-06-30 | -6.63x |
| 2021-03-31 | -43.55x |
| 2017-03-31 | -0.41x |
| 2016-12-31 | -0.48x |
| 2016-09-30 | -1.26x |
| 2016-06-30 | -0.37x |
| 2016-03-31 | -0.47x |
| 2015-12-31 | -0.54x |
| 2015-09-30 | -1.64x |
| 2015-06-30 | -0.90x |
| 2015-03-31 | -1.07x |
| 2014-12-31 | -1.05x |
| 2014-09-30 | -1.36x |
| 2014-06-30 | -0.55x |
| 2014-03-31 | -0.70x |
| 2013-12-31 | -0.83x |
| 2013-09-30 | -1.57x |
| 2013-06-30 | -0.77x |
| 2013-03-31 | -0.82x |
| 2012-12-31 | -0.87x |
| 2012-09-30 | -2.06x |
| 2012-06-30 | -0.61x |
| 2012-03-31 | -1.02x |
| 2011-12-31 | -0.96x |
| 2011-09-30 | -2.34x |
